SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : North American Vaccine
NVX 1.410-6.6%Nov 3 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Paul Lee who wrote (395)7/30/1998 3:25:00 PM
From: Don W Stone   of 507
 
It is my strongest opinion that the SHORTS ARE THE ONLY SELLERS

That the Longs have bought over 500,000 shares today, so far.
Why? No one of any intelligence would be a seller today. The only downside risk for the long term investor in this investment was just illiminated. The fundamental value of NVX just went up by a multiple with this approval. NVX is no longer just a development stage company in the fast grow international vaccine market.
What is going on in the stock market today mirrors what went on a few months back with Organgenesis. On the news of their FDA approval the shorts went at selling the stock for a day or so and then the stock went on to rally well beyond were it was on the news release. Not surprisingly the same shorts are involved in NVX.
I would hope at some point this may get the attention of the SEC.
This is about "STOCK MANIPULATION" .

Certainly the shorts have not had a single, substantiated, fundamental reason to short NVX.

IT IS ABOUT "MANIPULATING" THE PUBLIC IMAGE DF THE COMPANY THRU THE "MANIPULATION" OF THE MEDIA AND THE ACTIVITY OF THE STOCK IN THE MARKET.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext